Talecris Biotherapeutics Overview
- Year Founded
-
1942
- Status
-
Acquired/Merged
- Employees
-
5,400
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
1
Talecris Biotherapeutics General Information
Description
Provider of plasma-derived protein therapies worldwide. The company develops, produces, markets, and distributes therapies for the people suffering from chronic and acute immune deficiency disorders, alpha-1 antitrypsin deficiency, infectious diseases, hemophilia, and severe burns. Its also offers Hyperimmunes, which are antibody preparations for hepatitis, rabies, tetanus, and treatment of Rh negative women pregnant with Rh positive children; and albumin under various brand names, including Plasbumin albumin and Plasmanate plasma protein factor. In addition, the company provides plasma-derived hemostasis products to treat patients who lack the necessary factors for blood clotting and suffer from conditions in which clotting occurs; and PPF-powder for the fermentation of Kogenate.
Contact Information
Website
www.talecris.comCorporate Office
- 4101 Research Commons
- 79 T.W. Alexander Drive
- Durham, NC 27709
- United States
Corporate Office
- 4101 Research Commons
- 79 T.W. Alexander Drive
- Durham, NC 27709
- United States
Talecris Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Talecris Biotherapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Talecris Biotherapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Talecris Biotherapeutics Investments (1)
Talecris Biotherapeutics’s most recent deal was a Buyout/LBO with Talecris Plasma Resources. The deal was made on 20-Nov-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Talecris Plasma Resources | 20-Nov-2006 | Buyout/LBO | Other Healthcare Services |
Talecris Biotherapeutics FAQs
-
When was Talecris Biotherapeutics founded?
Talecris Biotherapeutics was founded in 1942.
-
Where is Talecris Biotherapeutics headquartered?
Talecris Biotherapeutics is headquartered in Durham, NC.
-
What is the size of Talecris Biotherapeutics?
Talecris Biotherapeutics has 5,400 total employees.
-
What industry is Talecris Biotherapeutics in?
Talecris Biotherapeutics’s primary industry is Pharmaceuticals.
-
Is Talecris Biotherapeutics a private or public company?
Talecris Biotherapeutics is a Private company.
-
What is the current valuation of Talecris Biotherapeutics?
The current valuation of Talecris Biotherapeutics is .
-
What is Talecris Biotherapeutics’s current revenue?
The current revenue for Talecris Biotherapeutics is .
-
How much funding has Talecris Biotherapeutics raised over time?
Talecris Biotherapeutics has raised $1.12B.
-
Who are Talecris Biotherapeutics’s investors?
Ampersand (Massachusetts) and Cerberus Capital Management have invested in Talecris Biotherapeutics.
-
When was Talecris Biotherapeutics acquired?
Talecris Biotherapeutics was acquired on 02-Jun-2011.
-
Who acquired Talecris Biotherapeutics?
Talecris Biotherapeutics was acquired by Grifols.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
